Soluble Urokinase Receptor (SuPAR) in COVID-19–Related AKI

BACKGROUND: AKI commonly occurs in patients with coronavirus disease 2019 (COVID-19). Its pathogenesis is poorly understood. The urokinase receptor system is a key regulator of the intersection between inflammation, immunity, and coagulation, and soluble urokinase plasminogen activator receptor (suP...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Am Soc Nephrol
Autori principali: Azam, Tariq U., Shadid, Husam R., Blakely, Pennelope, O’Hayer, Patrick, Berlin, Hanna, Pan, Michael, Zhao, Peiyao, Zhao, Lili, Pennathur, Subramaniam, Pop-Busui, Rodica, Altintas, Izzet, Tingleff, Jens, Stauning, Marius A., Andersen, Ove, Adami, Maria-Evangelia, Solomonidi, Nicky, Tsilika, Maria, Tober-Lau, Pinkus, Arnaoutoglou, Eleni, Keitel, Verena, Tacke, Frank, Chalkias, Athanasios, Loosen, Sven H., Giamarellos-Bourboulis, Evangelos J., Eugen-Olsen, Jesper, Reiser, Jochen, Hayek, Salim S.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society of Nephrology 2020
Soggetti:
Clinical Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7608953/
https://ncbi.nlm.nih.gov/pubmed/32963090
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2020060829
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi